-Business Standard India’s growth in agriculture and allied activities has struggled to reach the targeted four per cent average a year in the first three years of the 12th five-year Plan because of a host of factors. The below-average farm growth is widely expected to deepen the crisis in the farm sector. In an interview with Sanjeeb Mukherjee, newly-appointed member of NITI Aayog and eminent agriculture economist Ramesh Chand  said over-reliance...

-Down to Earth India’s public spending on health is among the lowest in South East Asia and BRIC countries The burden of aspirations and expectations seems to be taking a toll on young India, especially males who succumb to suicidal deaths more than their female counterparts, according to the data published by the Central Bureau of Health Intelligence (CBHI). The data showed that over 67 per cent cases of suicidal deaths in...

-The Times of India MORADABAD: The western UP district of Moradabad has for some time now been getting 50% of all printed circuit boards in India. No wonder then that it generates a staggering 9 tonnes of hazardous waste daily, with officials saying close to 50,000 people are involved in it. Most of the recycling is illegal and residents have now begun to panic. Confirming their worst fears, latest research by...

-The Hindu Business Line A narrow focus on growth-led development is the cause of the world’s sustainability crisis, not its solution The world’s political leaders meet in New York today to adopt a ‘sustainable development’ agenda. On the face of it, this sounds very hopeful. It signals that finally, humanity may move towards making peace with the earth, even as it erases the shame of over two billion people still living in...

-The Times of India WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight. Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in...